Historically, the production of insulin release was carried out at the beginning of his counterparts from the cells of animals. These compounds are different from human insulin structure, so in the future, scientists have started to make their chemical modification. However, the method proved too expensive for industrial production.
A little later, for the same purpose was used bacteria that are being genetically modified, are beginning to synthesize insulin analogue. This method is caught by the fact that required a less serious changes in the structure derived molecules.
The tests showed that the structure, physical properties and functionality of SBS-1000 corresponds to human insulin, as well as safe for health. First, scientists tested the compound in rodents and primates, and recently came up to the person. Now in the UK are the first stages of clinical trials: 30 healthy volunteers to test his action of synthetic hormones.
Scientists compare the effect of SBS-1000 with two other commercial preparations used to treat diabetes, and study its biological effect on humans. New method for insulin will significantly reduce production costs. In particular, it will not have to make complex and expensive process of bacteria.
In a press release the company noted that safflower in North America is almost grown. This means that he has almost no related species and, consequently, the likelihood is minimal loss of genes that are so necessary for the production of proinsulin from these plants.
About how diabetes and insulin shortage in the human body, struggling with the transplantation of cells , their re-programming , and more using natural function of bones .
A little later, for the same purpose was used bacteria that are being genetically modified, are beginning to synthesize insulin analogue. This method is caught by the fact that required a less serious changes in the structure derived molecules.
The tests showed that the structure, physical properties and functionality of SBS-1000 corresponds to human insulin, as well as safe for health. First, scientists tested the compound in rodents and primates, and recently came up to the person. Now in the UK are the first stages of clinical trials: 30 healthy volunteers to test his action of synthetic hormones.
Scientists compare the effect of SBS-1000 with two other commercial preparations used to treat diabetes, and study its biological effect on humans. New method for insulin will significantly reduce production costs. In particular, it will not have to make complex and expensive process of bacteria.
In a press release the company noted that safflower in North America is almost grown. This means that he has almost no related species and, consequently, the likelihood is minimal loss of genes that are so necessary for the production of proinsulin from these plants.
About how diabetes and insulin shortage in the human body, struggling with the transplantation of cells , their re-programming , and more using natural function of bones .
0 comments:
Post a Comment